Borsche et al. revealed that in individuals carrying mutations in PRKN/PINK1, IL6 and circulating cell-free mtDNA levels can serve as markers of Parkinson’s disease state and progression, respectively. This evidence concerns the gene PRKN and Parkinson disease.